Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

International Journal of Molecular Sciences(2021)10.3390/ijms23010004Source: DataRank Database

Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) is a research paper published in International Journal of Molecular Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: goldTopics (47)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Tadas Kasputis,Srinivas Nallandhighal ORCID,Sophia M. Abusamra ORCID,Amy Kasputis,Saloni Haruray ORCID

Live enrichment

PubMed:35008431 PMC:PMC8744626

Prostate Cancer Foundation

Grant: YIA

National Institutes of Health

Grant: 1R01CA240991

Prostate SPORE

Grant: P50 CA186786

Taubman Emerging Scholar Award

Grant: University of Michigan

National Institutes of Health

Grant: 5P50CA186786-09

Michigan Prostate SPORE

National Institutes of Health

Grant: 5R01CA240991-04

Determining the clinical impact of gene expression testing in localized prostate cancer

National Institutes of Health

Grant: 5P50CA186786-02

A Precision Medicine Approach to Elucidate Mechanisms of Progression

goldLicense: cc-by

publisherhttps://www.mdpi.com/1422-0067/23/1/4/pdf?version=1640074945

publisherhttps://www.mdpi.com/1422-0067/23/1/4/pdf

repositoryhttps://doaj.org/article/9735b663c5a84a45bcdc130635d0545f

repositoryhttps://dx.doi.org/10.3390/ijms23010004

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8744626

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansProstatic NeoplasmsAndrogen AntagonistsKallikreinsProstate-Specific AntigenReceptors, AndrogenAntigens, NeoplasmPrognosisProspective StudiesGene Expression ProfilingDrug Resistance, NeoplasmMaleDesmoglein 2Neoplastic Cells, CirculatingMultiplex Polymerase Chain ReactionBiomarkers, TumorPrecision MedicineMidkine

Keywords

PrognosticGene Expressionprostate cancerMetastaticCirculating Tumor CellsCtcsCastration-sensitiveHormone-sensitiveMaleArticleAntigens, NeoplasmBiomarkers, TumorHumansProspective StudiesPrecision MedicineDesmoglein 2Gene Expression ProfilingMidkineProstatic NeoplasmsAndrogen AntagonistsProstate-Specific AntigenNeoplastic Cells, CirculatingPrognosisDrug Resistance, NeoplasmReceptors, AndrogenKallikreinsMultiplex Polymerase Chain Reaction

Sustainable Development Goals

SDG 3: 3. Good health